Cel-Sci
CVM
#10602
Rank
โ‚ฌ22.41 M
Marketcap
1,28ย โ‚ฌ
Share price
-0.66%
Change (1 day)
-78.80%
Change (1 year)

EPS for Cel-Sci (CVM)

EPS in 2026 (TTM): -4,47ย โ‚ฌ

According to Cel-Sci 's latest financial reports the company's current EPS (TTM) is -4,37ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -5,43ย โ‚ฌ an increase over its 2024 EPS that were of -13,27ย โ‚ฌ.

EPS history for Cel-Sci from 1996 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-4,47ย โ‚ฌ-17.83%
2025-5,43ย โ‚ฌ-59.05%
2024-13,27ย โ‚ฌ-30.09%
2023-18,98ย โ‚ฌ-16.09%
2022-22,62ย โ‚ฌ-3.33%
2021-23,40ย โ‚ฌ9.76%
2020-21,32ย โ‚ฌ15.49%
2019-18,46ย โ‚ฌ-62.03%
2018-48,62ย โ‚ฌ2.19%
2017-47,58ย โ‚ฌ-22.78%
2016-61,62ย โ‚ฌ-77.45%
2015-273,27ย โ‚ฌ-13.14%
2014-314,61ย โ‚ฌ61.33%
2013-195,01ย โ‚ฌ-57.14%
2012-455,02ย โ‚ฌ-45.31%
2011-832,03ย โ‚ฌ-420%
2010260,01ย โ‚ฌ-112.9%
2009-2.015ย โ‚ฌ342.86%
2008-455,02ย โ‚ฌ-30%
2007-650,02ย โ‚ฌ-0%
2006-650,02ย โ‚ฌ150%
2005-260,01ย โ‚ฌ-0%
2004-260,01ย โ‚ฌ-75%
2003-1.040ย โ‚ฌ-54.29%
2002-2.275ย โ‚ฌ-31.37%
2001-3.315ย โ‚ฌ15.91%
2000-2.860ย โ‚ฌ-12.97%
1999-3.287ย โ‚ฌ-29.73%
1998-4.677ย โ‚ฌ-26%
1997-6.320ย โ‚ฌ-13.79%
1996-7.331ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
7,57ย โ‚ฌ-273.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
12,55ย โ‚ฌ-387.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
-1,98ย โ‚ฌ-54.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
-20,63ย โ‚ฌ 372.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
1,19ย โ‚ฌ-127.18%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
BioCryst Pharmaceuticals
BCRX
-1,50ย โ‚ฌ-65.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-0,15ย โ‚ฌ-96.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-1.419ย โ‚ฌ 32,375.20%๐Ÿ‡บ๐Ÿ‡ธ USA